EXI, a clinically-validated, personalized physical activity solution, has integrated Kemtai into its app to deliver AI-guided physical activity to its members.

,

EXI, a clinically-validated, personalized physical activity solution, has integrated Kemtai into its app to deliver AI-guided physical activity to its members.

EXI, a clinically-validated, personalized physical activity solution, has integrated Kemtai into its app to deliver AI-guided physical activity to its members.

NEW YORK, NY, UNITED STATES, April 11, 2024 /EINPresswire.com/ — EXI, a clinically-validated, personalized physical activity solution, has integrated Kemtai into its mobile application in order to deliver AI-guided physical activity to its members. Kemtai is a computer vision AI exercise platform that provides real-time feedback and corrective guidance to scale medical fitness and physical therapy. Kemtai has developed the most advanced computer vision motion tracking technology available in the market, which analyzes 111 body points, supports 2000+ different exercises, runs on any device with a camera, and does not require any hardware or sensors. This partnership marks EXI’s latest step in using cutting-edge technology to provide personalized programs to its growing member base.

With 78% of US adults living sedentary lifestyles and approximately 60% having at least one chronic condition, EXI aims to support a diverse member population. It was created with this population in mind, developed for individuals who simply strive to improve their physical activity or lose weight, those preparing for or recovering from surgeries (e.g., bariatric surgery, cardiac rehab), as well as many dealing with other chronic conditions (e.g., diabetes, depression). EXI takes exercise recommendations to the next level by providing automated, adaptive programs and personalized data insights. Kemtai supports this mission by bringing the next generation of guided physical activity, safe technique tracking, and adherence tracking to the homes of EXI members.

Please follow and like us: